Infectious complications of probiotic use: A matched case–control study

In this matched case–control study, we sought to determined the association between probiotic use and invasive infections caused by typical probiotic organisms. The odds of probiotic use in cases were 127 times the odds of probiotic use in controls (95% CI, 6.21–2600). Further research into these ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Tom, Florissa S., Tucker, Kendall J., McCracken, Caitlin M., McGregor, Jessina C., Gore, Sara J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588441/
https://www.ncbi.nlm.nih.gov/pubmed/34236023
http://dx.doi.org/10.1017/ice.2021.261
_version_ 1784814131379961856
author Tom, Florissa S.
Tucker, Kendall J.
McCracken, Caitlin M.
McGregor, Jessina C.
Gore, Sara J.
author_facet Tom, Florissa S.
Tucker, Kendall J.
McCracken, Caitlin M.
McGregor, Jessina C.
Gore, Sara J.
author_sort Tom, Florissa S.
collection PubMed
description In this matched case–control study, we sought to determined the association between probiotic use and invasive infections caused by typical probiotic organisms. The odds of probiotic use in cases were 127 times the odds of probiotic use in controls (95% CI, 6.21–2600). Further research into these rare but severe complications is needed.
format Online
Article
Text
id pubmed-9588441
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95884412022-10-26 Infectious complications of probiotic use: A matched case–control study Tom, Florissa S. Tucker, Kendall J. McCracken, Caitlin M. McGregor, Jessina C. Gore, Sara J. Infect Control Hosp Epidemiol Concise Communication In this matched case–control study, we sought to determined the association between probiotic use and invasive infections caused by typical probiotic organisms. The odds of probiotic use in cases were 127 times the odds of probiotic use in controls (95% CI, 6.21–2600). Further research into these rare but severe complications is needed. Cambridge University Press 2022-10 2021-07-08 /pmc/articles/PMC9588441/ /pubmed/34236023 http://dx.doi.org/10.1017/ice.2021.261 Text en © The Society for Healthcare Epidemiology of America 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Concise Communication
Tom, Florissa S.
Tucker, Kendall J.
McCracken, Caitlin M.
McGregor, Jessina C.
Gore, Sara J.
Infectious complications of probiotic use: A matched case–control study
title Infectious complications of probiotic use: A matched case–control study
title_full Infectious complications of probiotic use: A matched case–control study
title_fullStr Infectious complications of probiotic use: A matched case–control study
title_full_unstemmed Infectious complications of probiotic use: A matched case–control study
title_short Infectious complications of probiotic use: A matched case–control study
title_sort infectious complications of probiotic use: a matched case–control study
topic Concise Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588441/
https://www.ncbi.nlm.nih.gov/pubmed/34236023
http://dx.doi.org/10.1017/ice.2021.261
work_keys_str_mv AT tomflorissas infectiouscomplicationsofprobioticuseamatchedcasecontrolstudy
AT tuckerkendallj infectiouscomplicationsofprobioticuseamatchedcasecontrolstudy
AT mccrackencaitlinm infectiouscomplicationsofprobioticuseamatchedcasecontrolstudy
AT mcgregorjessinac infectiouscomplicationsofprobioticuseamatchedcasecontrolstudy
AT goresaraj infectiouscomplicationsofprobioticuseamatchedcasecontrolstudy

Ejemplares similares